Read + Share
Ilg MM, Lapthorn AR, Ralph DJ, Cellek S, et al. Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential
for repurposing for Peyronie's disease. PLoS One 2022;17:e0277646.
PMID: 36508413
|
 |
|
Ilg MM, Lapthorn AR, Ralph DJ, Cellek S, et al. Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential
for repurposing for Peyronie's disease. PLoS One 2022;17:e0277646.
PMID: 36508413
|
|
|
|